Skip to search formSkip to main contentSkip to account menu

SQ 29548

Known as: SQ-29548 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Hydrazines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Impact of Increased Intramuscular Perfusion Heterogeneity on Skeletal Muscle Microvascular Hematocrit in the Metabolic Syndrome
To determine HMV and PS in skeletal muscle of OZR and evaluate the impact of increased microvascular perfusion heterogeneity on… 
2013
2013
Rosuvastatin prevents angiotensin II‐induced vascular changes by inhibition of NAD(P)H oxidase and COX‐1
NAD(P)H oxidase and COX‐1 participate in vascular damage induced by angiotensin II. We investigated the effect of rosuvastatin on… 
2011
2011
Divergence between arterial perfusion and fatigue resistance in skeletal muscle in the metabolic syndrome
The metabolic syndrome is associated with elevated peripheral vascular disease risk, characterized by mismatched blood flow… 
2007
2007
Imbalanced synthesis of cyclooxygenase‐derived thromboxane A2 and prostacyclin compromises vasomotor function of the thoracic aorta in Marfan syndrome
Thoracic aortic dissection is a life‐threatening complication of Marfan syndrome, a connective tissue disorder caused by… 
2006
2006
Activation of the central cholinergic system mediates the reversal of hypotension by centrally administrated U-46619, a thromboxane A2 analog, in hemorrhaged rats
2003
2003
Effects of 8-iso-prostaglandin E2 and 8-iso-prostaglandin F2 alpha on the release of noradrenaline from the isolated rat stomach.
2002
2002
Thromboxane receptor signalling in human myometrial cells.
2001
2001
Changes in airway resistance by simultaneous exposure to TNF-α and IL-1β in perfused rat lungs
Tumor necrosis factor (TNF)-α and interleukin (IL)-1β are formed simultaneously under inflammatory conditions such as asthma and… 
1999
1999
Thromboxane A2 Receptor Antagonism in Man and Rat by a Sulphonylcyanoguanidine (BM‐144) and a Sulphonylurea (BM‐500)
Torasemide, a loop diuretic, has been reported to relax dog coronary artery precontracted by thromboxane A2 (TXA2), an endogenous… 
Highly Cited
1989
Highly Cited
1989
Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a…
Dynamic changes of the thrombus after its formation due to platelet activation may affect the speed of thrombolysis. In the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)